New Estimate On House’s Proposed Drug Bill Reports Fast Savings Of $345B To Taxpayers, Big Changes To Drugmakers

The bill proposes that Medicare establish prices based on a price index on other nation's sales. News on the industry looks at how Canada's transparency on drug trials differs from the U.S., as well.

from Kaiser Health News https://ift.tt/2B6IHq7